Premium
Guidelines for the Management of Vasa Previa
Author(s) -
Gag Robert,
Morin Lucie,
Bly Stephen,
Butt Kimberly,
Cargill Yvonne M.,
Denis Nanette,
Gag Robert,
HietalaCoyle Marja Anne,
Lim Kenneth Ian,
Ouellet Annie,
Racicot MariaHélène,
Salem Shia,
Gag Robert,
Hudon Lynda,
Basso Melanie,
Bos Hayley,
Delisle MarieFrance,
Farine Dan,
Grabowska Kirsten,
Menticoglou Savas,
Mundle William,
MurphyKaulbeck Lynn,
Ouellet Annie,
Pressey Tracy,
Roggensack Anne
Publication year - 2010
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2009.09.011
Subject(s) - medicine , guideline , observational study , randomized controlled trial , medline , cinahl , systematic review , cochrane library , caesarean section , pediatrics , intensive care medicine , pregnancy , surgery , nursing , psychological intervention , pathology , biology , political science , law , genetics
Abstract Objectives To describe the etiology of vasa previa and the risk factors and associated condition, to identify the various clinical presentations of vasa previa, to describe the ultrasound tools used in its diagnosis, and to describe the management of vasa previa. Outcomes Reduction of perinatal mortality, short‐term neonatal morbidity, long‐term infant morbidity, and short‐term and long‐term maternal morbidity and mortality. Evidence Published literature on randomized trials prospective cohort studies, and selected retrospective cohort studies was retrieved through searches of PubMed or Medline, CINAHL, and the Cochrane Library, using appropriate controlled vocabulary (e.g., selected epidemiological studies comparing delivery by Caesarean section with vaginal delivery studies comparing outcomes when vasa previa is diagnosed antenatally vs. intrapartum) and key words (e.g. vasa previa). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. Searches were updated on a regular basis and incorporated into the guideline to October 1, 2008. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology assessment‐related agencies, clinical practice guideline collections, clinical trial registries, and from national and international medical specialty societies. Values The evidence collected was reviewed by the Diagnostic Imaging Committee and the Maternal Fetal Medicine Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC) and quantified using the evaluation of evidence guidelines developed by the Canadian Task Force on Preventive Health Care. Benefits, Harms, and Costs The benefit expected from this guideline is facilitation of optimal and uniform care for pregnancies complicated by vasa previa. Sponsors The Society of Obstetricians and Gynaecologists of Canada.